Abstract
Cisplatin is widely used in the treatment of malignant patients; however, its adverse nephrotoxic effects limit its clinical use. Ginsenoside Rh1 is a main component of ginseng and has many pharmaceutical effects, including immunomodulatory effects. The objective of this research is to assess the effects of ginsenoside Rh1 on a cisplatin-induced HK-2 injury model and to study its potential effect mechanisms. HK-2 cell vitality was assessed via Cell Counting Kit-8 (CCK-8) assay. Carboxyfluorescein succinimidyl ester/propidium iodide (CFSF/PI) staining was used to detect the apoptosis of HK-2 cells. ROS expression was detected by DCFDA. The expressions of JNK, p53, caspase-3, Bax, and NGAL were detected by western blot. Ginsenoside Rh1 was found to increase the vitality of HK-2 cells and inhibit ROS production and the apoptosis of HK-2 cells in a cisplatin-induced injury model. Ginsenoside Rh1 was found to inhibit the expression of JNK, p53, caspase-3, Bax, and NGAL in a cisplatin-induced injury model. Ginsenoside Rh1 alleviated HK-2 apoptosis in a cisplatin-induced injury model by inhibiting ROS production and the JNK/p53 pathway. Ginsenoside Rh1 may be a promising drug for the alleviation of cisplatin-induced nephrotoxicity in ...Continue Reading
References
Mar 1, 1997·Cytometry·A W BoersmaG Stoter
Jul 4, 1998·British Journal of Cancer·R SkinnerA W Craft
Nov 15, 2001·The Journal of Biological Chemistry·Jonathan P GodboutGregory G Freund
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Brian S Cummings, Rick G Schnellmann
Sep 19, 2003·Seminars in Nephrology·Istvan Arany, Robert L Safirstein
Aug 19, 2004·American Journal of Physiology. Renal Physiology·Man JiangZheng Dong
Jul 4, 2006·Cellular Signalling·Elizabeth S Henson, Spencer B Gibson
Apr 18, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Heloísa D C FrancescatoTerezila M Coimbra
May 23, 2007·Journal of the Association for Research in Otolaryngology : JARO·Hongseob SoRaekil Park
Feb 27, 2008·Journal of Agricultural and Food Chemistry·Wenfei HeHiroyuki Kodama
May 28, 2009·Journal of the American Society of Nephrology : JASN·Bruce A MolitorisElena Feinstein
Oct 1, 2010·Kidney International·Zhengchao WangNingjun Li
Oct 26, 2010·Journal of Neurochemistry·Ji-Sun JungHee-Sun Kim
Dec 12, 2012·Cancer Chemotherapy and Pharmacology·Kosuke OkadaToru Yanagawa
Mar 8, 2013·Biochimica Et Biophysica Acta·Wei-Qing HanNingjun Li
May 21, 2013·Neurochemistry International·Ji-Sun JungHee-Sun Kim
Nov 22, 2013·PloS One·Rossella MarulloPaul W Doetsch
Sep 10, 2017·Journal of Experimental & Clinical Cancer Research : CR·Xiaomin FengZhimin He
Oct 5, 2017·Expert Review of Proteomics·Manish MishraAldrin V Gomes
Jan 13, 2018·Planta medica·Dao Ngoc Hien TamNguyen Tien Huy
Apr 22, 2018·British Journal of Pharmacology·Ming WangYing-Yong Zhao
Oct 1, 2018·Trends in Pharmacological Sciences·Dan-Qian ChenYing-Yong Zhao
Feb 5, 2019·Free Radical Biology & Medicine·Dan-Qian ChenYing-Yong Zhao
May 7, 2019·Frontiers in Pharmacology·Hai-Di LiJun Li
May 28, 2019·Medicinal Research Reviews·Ya-Long FengYing-Yong Zhao